Diaceutics PLC (AIM:DXRX)
London · Delayed Price · Currency is GBP · Price in GBX 128.00
+1.50 (1.19%)
Dec 31, 2025, 12:35 PM GMT+1
Diaceutics Market Cap
Diaceutics has a market cap or net worth of 108.68 million as of December 31, 2025. Its market cap has increased by 3.70% in one year.
Market Cap
108.68M
Enterprise Value
99.43M
Revenue
34.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
128.00
Market Cap Chart
Since March 21, 2019, Diaceutics's market cap has increased from 66.45M to 108.68M, an increase of 63.55%. That is a compound annual growth rate of 7.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 108.68M | 2.46% |
| Dec 31, 2024 | 106.07M | 44.67% |
| Dec 29, 2023 | 73.32M | 15.14% |
| Dec 30, 2022 | 63.68M | -25.74% |
| Dec 31, 2021 | 85.75M | -23.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 21, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.22B |
| GSK plc | 73.45B |
| Haleon | 33.27B |
| Smith & Nephew | 10.49B |
| Convatec Group | 4.72B |
| Hikma Pharmaceuticals | 3.43B |
| HUTCHMED (China) | 1.79B |
| Genus | 1.74B |